
Congress trades
DENTSPLY SIRONA Inc. (XRAY)
NASDAQ · Healthcare · 36 congress trades · last filed 2 years ago
About DENTSPLY SIRONA Inc.
from the company's filings and listing, as of Oct 24, 2026- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Chief executive
- Daniel T. Scavilla
- Employees
- 14,000
- Listed since
- Aug 12, 1987
- Market value
- $1.9B
- Price to earnings (12 mo)
- -
- Net income per share, as reported (12 mo)
- -$2.73
- Dividend yield
- 3.39%
Earnings
6 reported quarters · next on Nov 5, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 6, 2026 | $0.52 | $0.35 | $898.0M | $889.9M | EPS beatRevenue in line |
| Q1 FY2026reported May 5, 2026 | $0.27 | $0.28 | $880.0M | $841.8M | EPS missRevenue beat |
| Q4 FY2025reported Feb 26, 2026 | $0.27 | $0.28 | $961.0M | $926.2M | EPS missRevenue beat |
| Q3 FY2025reported Nov 6, 2025 | $0.37 | $0.45 | $904.0M | $927.1M | EPS missRevenue miss |
| Q2 FY2025reported Aug 7, 2025 | $0.52 | $0.50 | $936.0M | $904.6M | EPS beatRevenue beat |
| Q1 FY2025reported May 8, 2025 | $0.43 | $0.29 | $879.0M | $920.2M | EPS beatRevenue miss |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for fiscal 2025 · proxy filed Apr 23, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Daniel T. ScavillaPresident and Chief Executive Officer | $432K | $3.5M | $4.8M | $8.8M |
| Robert (Tony) A. JohnsonSenior Vice President, Chief Supply Chain Officer | $572K | $1.4M | $3.7M | $5.7M |
| Andrea L. FrohningSenior Vice President, Chief Human Resources Officer | $481K | $810K | $1.1M | $2.4M |
| Aldo M. DentiExecutive Vice President, Chief Commercial Officer | $188K | $0 | $1.3M | $1.5M |
The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. 3 executives who have since left the company are named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Shares vs prior qtr | % of shares out |
|---|---|---|---|---|
| BlackRock, Inc. | $283.4M | 26,711,079 | +38.7% | 13.38% |
| Fuller & Thaler Asset Management, Inc. | $134.7M | 12,697,269 | -0.7% | 6.36% |
| Vanguard Portfolio Management LLC | $125.0M | 11,779,851 | +11.9% | 5.90% |
| AQR Capital Management LLCCliff Asness | $110.2M | 10,458,771 | +163.8% | 5.24% |
| State Street Corp | $98.5M | 9,285,298 | +28.2% | 4.64% |
| Vanguard Capital Management LLC | $96.0M | 9,047,628 | +0.5% | 4.53% |
| Lazard Asset Management LLC | $87.7M | 8,269,867 | +23.1% | 4.14% |
| Ariel Investments, LLC | $85.2M | 8,026,107 | +25.7% | 4.02% |
| Southpoint Capital Advisors LP | $74.3M | 7,000,000 | -30.0% | 3.51% |
| Cooke & Bieler LP | $73.5M | 6,927,915 | -11.2% | 3.47% |
| Geode Capital Management, LLC | $60.0M | 5,650,605 | +47.8% | 2.83% |
| Invenomic Capital Management LP | $52.1M | 4,909,808 | +11.8% | 2.46% |
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
Congress trades in XRAY
20 disclosures of 36 on record · median 36d of the 45 allowedSince the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 25, 2026), not the member's result. Not investment advice.
| Member | Type | Action | Amount disclosed | Stock since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | -49.3%After the saleS&P 500 +29.0% · -78.4 pts vs S&P 500 | Jan 7, 2025 | Feb 11, 2025 | 35d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | -50.0%After the saleS&P 500 +28.9% · -78.8 pts vs S&P 500 | Jan 8, 2025 | Feb 11, 2025 | 34d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -67.7%After the saleS&P 500 +74.9% · -142.6 pts vs S&P 500 | Nov 3, 2023 | Dec 6, 2023 | 33d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -72.1%S&P 500 +77.9% · -150.0 pts vs S&P 500 | Oct 2, 2023 | Nov 8, 2023 | 37d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -76.2%S&P 500 +83.3% · -159.5 pts vs S&P 500 | May 2, 2022 | Jun 10, 2022 | 39d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | -77.6%After the saleS&P 500 +70.8% · -148.4 pts vs S&P 500 | Apr 19, 2022 | May 25, 2022 | 36d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -80.5%After the saleS&P 500 +72.7% · -153.3 pts vs S&P 500 | Apr 11, 2022 | May 6, 2022 | 25d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | -82.4%S&P 500 +66.2% · -148.6 pts vs S&P 500 | Feb 2, 2022 | Mar 17, 2022 | 43d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | -83.3%S&P 500 +70.3% · -153.7 pts vs S&P 500 | Feb 15, 2022 | Mar 17, 2022 | 30d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | -83.3%S&P 500 +70.1% · -153.5 pts vs S&P 500 | Feb 16, 2022 | Mar 17, 2022 | 29d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -82.3%After the saleS&P 500 +72.0% · -154.3 pts vs S&P 500 | Jan 28, 2022 | Feb 23, 2022 | 26d |
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | -81.4%After the saleS&P 500 +67.6% · -149.0 pts vs S&P 500 | Dec 3, 2021 | Jan 16, 2022 | 44d |
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | -81.7%After the saleS&P 500 +65.6% · -147.3 pts vs S&P 500 | Dec 5, 2021 | Jan 16, 2022 | 42d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -83.1%S&P 500 +62.2% · -145.3 pts vs S&P 500 | Nov 5, 2021 | Dec 7, 2021 | 32d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -85.3%After the saleS&P 500 +76.5% · -161.8 pts vs S&P 500 | Jul 1, 2021 | Aug 18, 2021 | 48d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | -85.3%After the saleS&P 500 +76.5% · -161.8 pts vs S&P 500 | Jul 1, 2021 | Aug 18, 2021 | 48d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | -82.6%S&P 500 +107.3% · -189.9 pts vs S&P 500 | Dec 10, 2020 | Jan 25, 2021 | 46d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -77.9%S&P 500 +134.7% · -212.6 pts vs S&P 500 | Sep 23, 2020 | Oct 21, 2020 | 28d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | -75.0%S&P 500 +165.6% · -240.6 pts vs S&P 500 | May 15, 2020 | Jun 15, 2020 | 31d |
| Michael T. McCaul | Stock | Purchase | $50,001 - $100,000 | -74.8%S&P 500 +201.8% · -276.7 pts vs S&P 500 | Apr 2, 2020 | May 18, 2020 | 46d |
Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no since-the-trade figure is computed from them.
Every Congress trade in XRAY, filterable by party, chamber, type and account.
Questions
Which members of Congress have traded XRAY?
Gilbert Ray Cisneros, Jr., Ro Khanna, Michael T. McCaul and Lois Frankel disclosed XRAY transactions in the filings shown here.
How quickly are XRAY trades disclosed?
Congressional disclosures took a median of 36 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 26, 2026.
